JNJ vs RNAZ · P/E 17, rev $49.37B vs $5.1M cap
Johnson & Johnson (JNJ) versus Transcode Therapeutics Inc (RNAZ) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Transcode Therapeutics Inc (RNAZ) is a biotechnology company listed on NASDAQ.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
RNAZ does not have a complete income-statement cache yet.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. RNAZ currently screens at market cap $5.1M.
Not investment advice. Open the JNJ and RNAZ stock pages for the full models.
Not investment advice.